We conducted a pan-cancer bioinformatic analysis of THAP9 and THAP9-AS1 focusing on their expression, patient prognosis, and genetic mutations in TCGA [30] and GTEx datasets [31] via TIMER2 [32], GEPIA2 [33] and cBio portal [34]. This evidence concerns the gene THAP9 and cancer.